CASH COLLECT AUTOCALLABLE WORST OF CERTIFICATE - BIONTECH ADR/BIOGEN IDEC/MODERNA CASH COLLECT AUTOCALLABLE WORST OF CERTIFICATE - BIONTECH ADR/BIOGEN IDEC/MODERNA Share Price
Certificat
UB26F8
DE000HB26F88
| Market Closed - Borsa Italiana 16:44:59 17/05/2024 BST | ||
| 42.21 EUR | -1.86% |
|
| Current month | +4.17% | ||
| 1 month | +11.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 42.21 | -1.86% |
| 16/05/24 | 43.01 | +2.67% |
| 15/05/24 | 41.89 | -1.32% |
| 14/05/24 | 42.45 | -0.19% |
| 13/05/24 | 42.53 | +0.21% |
Real-time Borsa Italiana
Last update May 17, 2024 at 04:44 pm
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| UB26F8 | |
| ISIN | DE000HB26F88 |
| Date issued | 30/12/2021 |
| Maturity | 12/12/2024 (208 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 111 € |
|---|---|
| Lowest since issue | 32.92 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6
USD
Average target price
285.9
USD
Spread / Average Target
+24.01%
- Stock Market
- Certificates
- UB26F8 Certificat
